THE USAGE OF PROBIOTICS IN CASE OF DISEASES OF THE GASTROINTESTINAL TRACT ASSOCIATED WITH OTHER PATHOLOGICAL PROCESSES: FOR AND AGAINST
DOI:
https://doi.org/10.32782/2786-9067-2023-25-2Keywords:
gastrointestinal tract, microorganisms, probiotics, antibioticresistance, immunity.Abstract
Abstract. According to general conclusion of literature facts of Ukrainian and foreign authors we have the sight of the necessity of prophylaxis of gastrointestinal diseases caused by more usage of antibiotics, immunosuppressive therapy, oncological pathology, consumption of the low-quality products, as well as perspectives of the usage of probiotics in medical practice. They analyzed 27 sources of Ukrainian and foreign literature. They presented the modern sight on the expedience of the usage of probiotics in case of diseases of the gastrointestinal tract associated with infections, pathological processes, in the pathogenesis of which immune disorders play an important role.
References
Tannok GW. Analysis intestinal microflora: A renaissance. Antonie van Leeuwenhoek. 2019; V. 76 N 1-4: P.265–278.
Dunne C. Murphy L., Flynn S, et al. Probiotics: from myth to reality. Demonstration functionality in animal models disease and an human clinical frials. Ibid. 2019; V. 76 N1-4: P.279-292.
Калініченко С.В., Коротких О.О., Тищенко І.Ю. Актуальні напрями створення та вдосконалення пробіотиків. Український біофармацевтичний журнал. 2016; №1(42): C.4–10.
Gupta V, Garg R. Probiotics. Indian J. Med Microbiol. 2009 Jul-Sep; N 27(3): 202–9. doi: 10.4103/0255-0857.53201.(Last accessed: 05.03.2023).
Marteau P, Cuillerier E, Meance S, Gerhardt MF., Myara A, Bouvier M, et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther. 2002 Mar; N16(3): P.587–93. doi: 10.1046/j.1365-2036.2002.01188.x. (Last accessed: 01.03.2023).
Guarner F, Sanders ME, Eliakim R. Probiotics and prebiotics: World Gastroenterology Organisation Global Guidelines. 2017: 35 p.
Harbarth S, Samore M. Antimicrobial Resistance Determinants and Future Control. Emerg Infect Dis. 2005 Jun; N 11(6): P. 794–801. doi: 10.3201/eid1106.050167. ( Last accessed: 01.03.2023).
Michael de Vrese, Philippe R. Marteau. Probiotics and prebiotics: effects on diarrhea. J Nutr. 2007 Mar; N 137(3): P.803–11. doi: 10.1093/jn/137.3.803S. (Last accessed: 05.03.2023).
Hyun J, Romero L, Riveron R, Flores C, Kanagavelu S, Chung KD, et al. Human intestinal epithelial cells express interleukin-10 through Toll-like receptor 4-mediated epithelial-macrophage crosstalk. J Innate Immun. 2015; N 7(1): P.87–101. doi: 10.1159/000365417.
Saavedra J. Probiotics and infectious diarrhea. Am J Gastroenterol. 2000 Jan; N 95(1): P.16–8. doi: 10.1016/s0002-9270(99)00811-4. (Last accessed: 10.02.2023).
Lannitti T, Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr. 2010 Dec; N 29(6): P.701–25. doi: 10.1016/j.clnu.2010.05.004.(Last accessed: 01.03.2023).
Mombell B, Gismondo MR. The use of probiotics in medical practice. Int J Antimicrob Agents. 2000 Dec; N16(4): P.531–6. doi: 10.1016/s0924-8579(00)00322-8. (Last accessed: 01.03.2023).
Hilton E, Isenberg HD., Aplerstein P, France K, Borenstein MT. Ingestion of yoghurt containing Lactobacillus acidophilus as prophylaxis for candida vaginitis. Ann. Int. Med. 2002; N116: P.353–7.
Chukeatirote E. Potential use of probiotics. J Sci Technol. 2003; N 25(2): P. 275–82.
Ji GE. Probiotics in primary prevention of atopic dermatitis. Forum Nutr. 2009; N61: P.117–128.
Lei M, Guo C, Wang D, Zhang C, Hua L. The effect of probiotic Lactobacillus casei Shirota on knee osteoarthritis: a randomised double-blind, placebo-controlled clinical trial. Benef Microbes. 2017 Oct; N 8(5): P.697–703. doi: 10.3920/BM2016.0207. (Last accessed: 01.03.2023).
Taye I, Bradbury J, Grace S, Avila C. Probiotics for pain of osteoarthritis; An N-of-1 trial of individual effects. Complement Ther Med. 2020 Nov; N 54: P.102-548. doi: 10.1016/j.ctim.2020.102548.
Korotkyi O, Dvorshchenko K, Falalyeyeva T, Sulaieva O, Kobyliak N, Abenavoli L, et al. Combined effects of probiotic and chondroprotector during osteoarthritis in rats. Panminerva Med. 2020 Jun; N 62(2): P.93–101. doi: 10.23736/S0031-0808.20.03841-0.
Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015 May; N 60(Suppl 2): P.129–134. doi: 10.1093/cid/civ085.
Zawistowska-Rojek A, Tyski S. Are Probiotic Really Safe for Humans. Pol J Microbiol. 2018; N 67(3): P.251–8. doi: 10.21307/pjm-2018-044.
De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J. 2005 Mar; N 24: P.278–80. doi: 10.1097/01.inf.0000154588.79356.e6. (Last accessed: 01.02.2023).
Ledoux D, Labombardi VJ, Karter D. Lactobacillus acidophilus bacteremia after use of a probiotic in a patient with AIDS and Hodgkin’s disease. Int J STD AIDS. 2006 Apr; N 17: P.280–2. doi: 10.1258/095646206776253507. (Last accessed: 11.02.2023).
Vahabnezhad E, Mochon AB, Wozniak LJ, Ziring DA. Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol. 2013 May-Jun; N 47: P.437–39. doi: 10.1097/MCG.0b013e318279abf0.
Dong H, Rowland I, Yaqoob P. Comparative effects of six probiotic strains on immune function in vitro. Br J Nutr. 2012 Aug;108(3):459–70. doi: 10.1017/S0007114511005824.
Zegarra-Ruiz DF, El Beidaq A, Iñiguez AJ, Di Ricco ML, Vieira SM, Ruff WE, et al. A Diet-Sensitive Commensal Lactobacillus Strain Mediates TLR7-Dependent Systemic Autoimmunity. Cell Host Microbe. 2019 Jan; N 25(1): P. 113–27. doi: 10.1016/j.chom.2018.11.009.
Penaloza-Vazquez A. Bacillus species are Superior Probiotic Feed-Additives for Poultry. J Bacteriol Mycol. 2016; N 2 (3): P. 57-59.
Wieërs G, Belkhir L, Enaud R, Leclercq S, Philippart de Foy JM, Dequenne I, et al. How Probiotics Affect the Microbiota. Front Cell Infect Microbiol. 2020 Jan; N 9: P.454. doi: 10.3389/fcimb.2019.00454.
